
Journal Menu
► ▼ Journal Menu-
- Viruses Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
8 December 2022
MDPI Sustainability Foundation: New Look and Nominations for the 2023 Sustainability Awards Now Open
We are pleased to announce that the website of the MDPI Sustainability Foundation has been revamped! For the past couple of months, our UX UI team and front-end developers have been working hard to launch the website in time for the opening of the Sustainability Awards nominations.
The website is not the only thing that has had a remodeling. Indeed, the format of the Emerging Sustainability Leader Award (ESLA) has been updated. ESLA is now a competition open to individual researchers or start-ups founded by researchers under the age of 35. Nominee applications will go through 2 rounds of selection until the final 3 are decided. The finalists will then be invited to give pitch presentations during the Award Ceremony to win either first place (10,000 USD) or runner-up (2 x 5000 USD).
The World Sustainability Award, on the other hand, remains the same: a total prize money of 100,000 USD is up for grabs by senior individual researchers or groups of researchers from the international research community.
Nominations for both the World Sustainability Award and the Emerging Sustainability Leader award are now open! Check out our new website for more information on how to nominate.
5 December 2022
Viruses | Seeking Cooperation with Academic Conferences
Viruses (ISSN: 1999-4915) is an open access journal that provides an advanced forum for studies of viruses. It publishes reviews, regular research papers, communications, conference reports, and short notes. Our aim is to publish papers that have a significant impact on the virology community. We encourage scientists to publish their experimental and theoretical results in as much detail as possible.
The full experimental details must be provided so that the results can be reproduced. There is no restriction on the length of the papers. We also encourage the publication of timely reviews and commentaries on topics of interest to the virology community. Papers are either published in the open journal or in Special Issues devoted to specific topics of interest to the field. We accept proposals for review articles that are not part of Special Issues.
In order to support the scientific community and contribute to the faster distribution of important scientific research, Viruses has cooperated with various academic conferences and is now seeking cooperation with additional academic conferences. The journal is open to a diverse range of collaborations, such as media partnerships, awards, exhibitions, and publications.
The scope of Viruses includes, but is not limited to, the following:
- Virus, viruses, virion, virology, virological, viral, viral infections, virologist;
- Virus classification;
- Virus-like agents, viroids, prions;
- Bacteriophage;
- Vaccines, viral immunology;
- Antiviral drugs, antiviral therapy, antiviral drug development;
- Origin of viruses, viral evolution;
- Virus structures, genomes;
- Virus dynamics, mathematical and simulation models of virus infections.
We welcome consultations with any conferences related to Viruses. If you are interested in collaborating with Viruses, please contact us at viruses@mdpi.com.
1 December 2022
Editorial Board Members from Viruses Featured in the 2022 Highly Cited Researchers List Published by Clarivate

Recently, ClarivateTM revealed its 2022 list of Highly Cited Researchers™—Individuals at universities, research institutes and commercial organizations.
The scientists who were selected into this year’s list of Highly Cited Researchers have published highly cited papers in the 11-year period from January 2011 to December 2021, with citation frequency in the top 1% of academic subjects and the same year of publication in the Web of ScienceTM database. Based on Web of Science Citation data, 6,938 researchers from across the globe who have demonstrated a disproportionate level of significant and broad influence in their chosen field or fields over the last decade have been awarded Highly Cited Researcher 2022 designations. The list is truly global, spanning 69 countries or regions and spread across a diverse range of research sciences and social sciences.
According to statistics, 8 members of the Editorial Board of Viruses (ISSN: 1999-4915) have been selected into the list of Highly Cited Researchers of Clarivate in 2022. They are being recognized for their high-quality scientific research achievements and outstanding contributions to professional fields. The Viruses journal office sincerely congratulates all elected Editorial Board Members and hopes that they continue to have an academically productive relationship with the journal.
Name |
Affiliation |
Prof. Dr. Ke Lan |
Wuhan University, China |
Prof. Dr. Mark J. Mulligan |
NYU Langone Vaccine Center, USA |
Prof. Dr. Nikos Vasilakis |
University of Texas Medical Branch, USA |
Prof. Dr. Stanley Perlman |
University of Iowa, USA |
Prof. Dr. Yu Chen |
Wuhan University, China |
Prof. Dr. Shibo Jiang |
Fudan University, China |
Prof. Dr. Stefan Pöhlmann |
German Primate Center, Germany |
Prof. Dr. Guy Smagghe |
Ghent University, Belgium |
8 November 2022
Editorial Board Members from Viruses Featured in Stanford’s List of the World’s Top 2% Scientists
Stanford University has recently published an update of the list of the top 2% most widely cited scientists—the World’s Top 2% Scientists.
The time node of the statistical data of this list is from 1960 to 2022, and it is divided into two lists: "Lifetime Scientific Influence Ranking" and "2022 Annual Scientific Influence Ranking". The "Lifetime Scientific Influence Ranking" counts the comprehensive influence performance of scientists during their careers, and the "2022 Annual Influence Ranking" focuses on highlighting the academic influence of scientists in the previous year. This ranking, considered the most prestigious worldwide, is based on the bibliometric information contained in the Scopus database and includes more than 200,000 researchers from the more than 10 million scientists considered to be active worldwide, with 22 scientific fields and 176 subfields taken into account.
We are pleased to share that 83 Editorial Board Members from MDPI’s journal Viruses (ISSN: 1999-4915) were featured in Stanford University’s list of World’s Top 2% Scientists in 2022.
Name |
Affiliation |
Dr. Akira Ono |
University of Michigan, USA |
Prof. Dr. Alexander Bukreyev |
University of Texas Medical Branch, USA |
Prof. Dr. Andrew Pekosz |
Johns Hopkins University, USA |
Prof. Dr. Alexander Ploss |
Princeton University, USA |
Prof. Dr. Artur Summerfield |
Institute of Virology and Immunology (IVI), Switzerland |
Prof. Dr. Ayato Takada |
Hokkaido University, Japan |
Prof. Dr. Barbara Baker |
University of California, USA |
Dr. Birke Bartosch |
Centre de recherche en cancérologie de Lyon, France |
Dr. Krisztián Bányai |
Veterinary Medical Research Institute, Hungary |
Dr. Covadonga Alonso |
Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria, Spain |
Prof. Dr. Charles Grose |
University of Iowa, USA |
Prof. Dr. Hualan Chen |
Chinese Academy of Agricultural Sciences, China |
Prof. Dr. Yu Chen |
Wuhan University, China |
Prof. Dr. Christopher S. Sullivan |
The University of Texas at Austin, USA |
Prof. Dr. Clinton Jones |
Oklahoma State University, USA |
Prof. Dr. Craig Meyers |
Pennsylvania State College of Medicine, USA |
Prof. Dr. Craig E. Cameron |
The University of North Carolina at Chapel Hill, USA |
Dr. Craig McCormick |
Dalhousie University, Canada |
Prof. Dr. Henryk H. Czosnek |
The Hebrew University of Jerusalem, Israel |
Dr. Blossom Damania |
University of North Carolina at Chapel Hill, USA |
Dr. Daniel DiMaio |
Yale University, USA |
Dr. Daniel L. Rock |
the University of Illinois at Urbana-Champaign, USA |
Prof. Dr. Terje Dokland |
University of Alabama at Birmingham, USA |
Dr. Eric O. Freed |
National Cancer Institute, USA |
Dr. Eugene V. Ryabov |
Beltsville Agricultural Research Center, USDA, USA |
Prof. Dr. Giorgio Palù |
University of Padova, Italy |
Prof. Dr. Guangxiang Luo |
University of Alabama at Birmingham School of Medicine, USA |
Prof. Dr. Graciela Andrei |
Rega Institute for Medical Research, Belgium |
Prof. Dr. Haitao Guo |
University of Pittsburgh, USA |
Prof. Dr. Guy Smagghe |
Ghent University, Belgium |
Dr. Helle Bielefeldt-Ohmann |
The University of Queensland, Australia |
Dr. Hernan Garcia-Ruiz |
University of Nebraska-Lincoln, Lincoln, USA |
Dr. Jason Kindrachuk |
University of Manitoba, Canada |
Prof. Dr. Jianming Hu |
Pennsylvania State University College of Medicine, USA |
Prof. Dr. K. Andrew White |
York University, Canada |
Prof. Dr. Ke Lan |
Wuhan University, China |
Dr. Koichi Watashi |
National Institute of Infectious Diseases, Japan |
Prof. Dr. Lennart Svensson |
Linköping University, Sweden |
Prof. Dr. Shuwen Liu |
Southern Medical University, China |
Dr. Luis Martinez-Sobrido |
Texas Biomedical Research Institute, San Antonio, USA |
Dr. Luis Menéndez-Arias |
Universidad Autónoma de Madrid, Spain |
Dr. Kenneth Lundstrom |
PanTherapeutics, Switzerland |
Prof. Dr. Michael J. Buchmeier |
University of California, USA |
Prof. Dr. Marc Kvansakul |
La Trobe University, Australia |
Prof. Dr. Louis M. Mansky |
University of Minnesota, USA |
Prof. Dr. Mark J. Mulligan |
NYU Grossman School of Medicine, USA |
Dr. Markus Thali |
University of Vermont, USA |
Prof. Dr. Matthias J. Schnell |
Sidney Kimmel Medical College at Thomas Jefferson University, USA |
Dr. Maurizia Rossana Brunetto |
University Hospital of Pisa, Italy |
Prof. Dr. Mikael Skurnik |
Medicum, University of Helsinki, Finland |
Prof. Dr. Manuel Ramos-Casals |
Department of Autoimmune Diseases, ICMID, Hospital Clinic, Spain |
Prof. Dr. Niklas Arnberg |
Umeå University, Sweden |
Prof. Dr. Nikos Vasilakis |
University of Texas Medical Branch, USA |
Prof. Dr. Norbert Nowotny |
University of Veterinary Medicine, Austria |
Prof. Dr. Nancy Raab-Traub |
University of North Carolina, USA |
Prof. Dr. Nobuhiro Suzuki |
Okayama University, Japan |
Prof. Dr. Oliver T. Fackler |
University Hospital Heidelberg, Germany |
Prof. Dr. Peng Zhou |
Wuhan Institute of Virology, Chinese Academy of Sciences, China |
Prof. Dr. Polly Roy |
London School of Hygiene, UK |
Dr. Rollie J. Clem |
Kansas State University, USA |
Prof. Dr. Regina Hofmann-Lehmann |
University of Zurich, Switzerland |
Prof. Dr. Rob Lavigne |
KU Leuven, Belgium |
Prof. Dr. Robert Thimme |
University Hospital Freiburg, Germany |
Dr. Romain Paillot |
Writtle University College, UK |
Prof. Dr. Satya Parida |
Food and Agriculture Organization of the United Nations, Italy |
Prof. Dr. Shibo Jiang |
Fudan University, China |
Prof. Dr. Shinji Makino |
The University of Texas Medical Branch, USA |
Prof. Dr. Shannon C. Kenney |
University of Wisconsin-Madison, USA |
Prof. Dr. Mark K. Slifka |
Oregon Health & Science University, USA |
Prof. Dr. Stefan Pöhlmann |
Infection Biology Unit, German Primate Center, Germany |
Prof. Dr. Stanley Perlman |
University of Iowa, USA |
Prof. Dr. Akinori Takaoka |
Hokkaido University, Japan |
Prof. Dr. Hengli Tang |
Florida State University, USA |
Prof. Dr. Thomas Hohn |
University of Basel, Switzerland |
Prof. Dr. Tina Dalianis |
Karolinska Institutet, Sweden |
Prof. Dr. Toshiki Watanabe |
St. Marianna University Graduate School, Japan |
Prof. Dr. Enzo Tramontano |
University of Cagliari, Italy |
Prof. Dr. Bin He |
University of Illinois, USA |
Dr. Ulrich Desselberger |
University of Cambridge, UK |
Dr. Volker Nickeleit |
The University of North Carolina School of Medicine, USA |
Prof. Dr. Volker Lohmann |
University of Heidelberg, Germany |
Dr. Weiyong Liu |
Huazhong University of Science and Technology, China |
Dr. Zongdi Feng |
The Ohio State University College of Medicine, USA |
The latest Stanford rankings reflect the significant influence and research excellence of the scientists, who are committed to furthering their knowledge for the benefit of the world.
We would like to congratulate our Editorial Board Members on their excellent achievement and thank them for their immense contribution to the scientific progression and development of Viruses.
1 November 2022
Viruses | Editor’s Choice Articles in 2020–2021
We are pleased to invite you to read the Editor’s Choice Articles of Viruses (ISSN: 1999-4915). A list of the high-quality and interesting papers that were specifically recommended by our Editorial Board Members can be found at the following link: https://www.mdpi.com/journal/viruses/editors_choice.
The papers list is as follows:
“The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner” |
“Semipersistently Transmitted, Phloem Limited Plant Viruses Are Inoculated during the First Subphase of Intracellular Stylet Penetrations in Phloem Cells” |
“Global Metabolic Profiling of Baculovirus Infection in Silkworm Hemolymph Shows the Importance of Amino-Acid Metabolism” |
“Microglial HIV-1 Expression: Role in HIV-1 Associated Neurocognitive Disorders” |
“Tracking HIV-1-Infected Cell Clones Using Integration Site-Specific qPCR” |
“Modular Evolution of Coronavirus Genomes” |
“A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines” |
“Molecular Evolution and Epidemiological Characteristics of SARS COV-2 in (Northwestern) Poland” |
“Effects of Basic Amino Acids and Their Derivatives on SARS-CoV-2 and Influenza-A Virus Infection” |
“A Diverse Viral Community from Predatory Wasps in Their Native and Invaded Range, with a New Virus Infectious to Honey Bees“ |
“Characterization of the Roles of SGT1/RAR1, EDS1/NDR1, NPR1, and NRC/ADR1/NRG1 in Sw-5b-Mediated Resistance to Tomato Spotted Wilt Virus” |
“Understanding the Genetic Diversity of Picobirnavirus: A Classification Update Based on Phylogenetic and Pairwise Sequence Comparison Approaches” by Lester J. P., Gavin A. C. and Michael G. B. |
“An Absolutely Conserved Tryptophan in the Stem of the Envelope Protein E of Flaviviruses Is Essential for the Formation of Stable Particles” |
“Examining the Effects of an Anti-Salmonella Bacteriophage Preparation, BAFASAL®, on Ex-Vivo Human Gut Microbiome Composition and Function Using a Multi-Omics Approach” |
“Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses“ |
“Report of One-Year Prospective Surveillance of SARS-CoV-2 in Dogs and Cats in France with Various Exposure Risks: Confirmation of a Low Prevalence of Shedding, Detection and Complete Sequencing of an Alpha Variant in a Cat” |
“Histotype-Dependent Oligodendroglial PrP Pathology in Sporadic CJD: A Frequent Feature of the M2C “Strain” |
“The Isolated in Utero Environment Is Conducive to the Emergence of RNA and DNA Virus Variants” |
“Phylogenomic Characterization of Lopma Virus and Praja Virus, Two Novel Rodent-Borne Arteriviruses” |
“The Pathobiology of H7N3 Low and High Pathogenicity Avian Influenza Viruses from the United States Outbreak in 2020 Differs between Turkeys and Chickens” |
“VP8, the Major Tegument Protein of Bovine Herpesvirus-1, Is Partially Packaged during Early Tegument Formation in a VP22-Dependent Manner” |
“Reduced Infection Efficiency of Phage NCTC 12673 on Non-Motile Campylobacter jejuni Strains Is Related to Oxidative Stress” |
“Phage Therapy Related Microbial Succession Associated with Successful Clinical Outcome for a Recurrent Urinary Tract Infection” |
“Spillover of West Caucasian Bat Lyssavirus (WCBV) in a Domestic Cat and Westward Expansion in the Palearctic Region” |
“Herpes Simplex Virus 1 and 2 Infections during Differentiation of Human Cortical Neurons” |
“Comparison of the Proteomes of Porcine Macrophages and a Stable Porcine Cell Line after Infection with African Swine Fever Virus” |
“SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism” |
“Downregulation of Cell Surface Major Histocompatibility Complex Class I Expression Is Mediated by the Left-End Transcription Unit of Fowl Adenovirus 9” |
“Impact of Phage CDHS-1 on the Transcription, Physiology and Pathogenicity of a Clostridioides difficile Ribotype 027 Strain, R20291” |
“Analyses of Leishmania-LRV Co-Phylogenetic Patterns and Evolutionary Variability of Viral Proteins” |
“Heterogeneity of Early Host Response to Infection with Four Low-Pathogenic H7 Viruses with a Different Evolutionary History in the Field” |
“Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection” |
“Characterization and Tissue Tropism of Newly Identified Iflavirus and Negeviruses in Glossina morsitans morsitans Tsetse Flies” |
|
13 October 2022
Viruses 2022 Early Career Investigator Award—Open for Nominations

We are pleased to announce that Viruses (ISSN: 1999-4915) is now welcoming nominations for the Viruses 2022 Early Career Investigator Award. This prize will be awarded to two early career investigators demonstrating excellence in virology. The nominations will be assessed by an Evaluation Committee chaired by the journal’s Editor-in-Chief, Dr. Eric O. Freed.
Prizes:
- Prize of CHF 1000;
- Invitation to publish one paper free of charge in the journal in 2023, following peer review;
- An invitation to speak at the Viruses international virology conference in 2024, and an engraved plaque.
Award Terms and Conditions:
- Nominees should be early career researchers with untenured positions who are within 10 years of having completed their most recent degree (Ph.D., M.D., or equivalent);
- Nominees must have produced ground-breaking research and made a significant contribution to the field of virology.
List of Documents for Nomination:
- A detailed curriculum vitae, including an updated publication list;
- Signed nomination letters and letters of recommendation from two established senior scientists.
Find more information about the award and how to nominate here.
To request further information, please contact the Viruses Editorial Office (viruses@mdpi.com).
28 September 2022
Peer Review Week 2022 – Research Integrity: Creating and Supporting Trust in Research

Peer Review Week began 19 September 2022 under the theme of “Research Integrity: Creating and Supporting Trust in Research”. Through various blog articles, podcast, and webinar, we discussed this crucial subject throughout the week, celebrating the essential role peer review plays in maintaining research quality.
To begin, we held a Webinar on the topic. Professor Peter W. Choate and Dr. Emmanuel Obeng-Gyasi joined Dr. Ioana Craciun, one of MDPI’s scientific officers, for an in-depth discussion.
We invite you to view the event recording:
During the week, the MDPI Blog in a series articles highlighted how good Peer Review safeguards research integrity. The following topics were covered:
- Peer Review Week 2022
- Research Integrity
- What We’ve Learned About Peer Review Reports
- 4 Steps to the Perfect Peer Review Report
- How to Write the Perfect Peer Review Report: An Interview
- Inviting Great Peer Reviewers
In a new edition of Insight Faster, an MDPI podcast, we were delighted to talk to the co-chairs of the Peer Review Week committee, Jayashree Rajagopalan (Senior Manager of Global Community Engagement for CACTUS) and Danielle Padula (Head of Marketing and Community Development at Scholastica) to get their take on this year’s event and its related topics.
You can find the Podcast here.
We hope you enjoy the contents!
14 September 2022
Viruses | Top Cited Papers in 2021
1. “Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech)”
by Johannes Korth et al.
Viruses 2021, 13(5), 756; https://doi.org/10.3390/v13050756
Available online: https://www.mdpi.com/1999-4915/13/5/756
Cited by 92 | Viewed by 2845
2. “Domains and Functions of Spike Protein in SARS-Cov-2 in the Context of Vaccine Design”
by Xuhua Xia
Viruses 2021, 13(1), 109; https://doi.org/10.3390/v13010109
Available online: https://www.mdpi.com/1999-4915/13/1/109
Cited by 91 | Viewed by 16009
3. “Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice”
by Pratima Kumari et al.
Viruses 2021, 13(1), 132; https://doi.org/10.3390/v13010132
Available online: https://www.mdpi.com/1999-4915/13/1/132
Cited by 82 | Viewed by 30382
4. “Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection”
by Federico Gobbi et al.
Viruses 2021, 13(3), 422; https://doi.org/10.3390/v13030422
Available online: https://www.mdpi.com/1999-4915/13/3/422
Cited by 80 | Viewed by 12495
5. “Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?”
by Ivana Lazarevic et al.
Viruses 2021, 13(7), 1192; https://doi.org/10.3390/v13071192
Available online: https://www.mdpi.com/1999-4915/13/7/1192
Cited by 79 | Viewed by 8279
6. “A Roadmap for Genome-Based Phage Taxonomy”
by Dann Turner et al.
Viruses 2021, 13(3), 506; https://doi.org/10.3390/v13030506
Available online: https://www.mdpi.com/1999-4915/13/3/506
Cited by 75 | Viewed by 5498
7. “Attitudes towards Anti-SARS-CoV2 Vaccination among Healthcare Workers: Results from a National Survey in Italy”
by Francesco Di Gennaro et al.
Viruses 2021, 13(3), 371; https://doi.org/10.3390/v13030371
Available online: https://www.mdpi.com/1999-4915/13/3/371
Cited by 72 | Viewed by 3020
8. “Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms”
by Bruno Silva Andrade et al.
Viruses 2021, 13(4), 700; https://doi.org/10.3390/v13040700
Available online: https://www.mdpi.com/1999-4915/13/4/700
Cited by 69 | Viewed by 12025
9. “Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications”
by Jasdeep Singh et al.
Viruses 2021, 13(3), 439; https://doi.org/10.3390/v13030439
Available online: https://www.mdpi.com/1999-4915/13/3/439
Cited by 65 | Viewed by 5564
10. “Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease”
by Lukas van de Sand et al.
Viruses 2021, 13(4), 609; https://doi.org/10.3390/v13040609
Available online: https://www.mdpi.com/1999-4915/13/4/609
Cited by 59 | Viewed by 4984
14 September 2022
Viruses | Top Cited Papers in 2020
1. “Virology, Epidemiology, Pathogenesis, and Control of COVID-19”
by Yuefei Jin et al.
Viruses 2020, 12(4), 372; https://doi.org/10.3390/v12040372
Available online: https://www.mdpi.com/1999-4915/12/4/372
Cited by 751 | Viewed by 75036
2. “Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies”
by Syed Faraz Ahmed et al.
Viruses 2020, 12(3), 254; https://doi.org/10.3390/v12030254
Available online: https://www.mdpi.com/1999-4915/12/3/254
Cited by 687 | Viewed by 59383
3. “Return of the Coronavirus: 2019-nCoV”
by Lisa E. Gralinski et al.
Viruses 2020, 12(2), 135; https://doi.org/10.3390/v12020135
Available online: https://www.mdpi.com/1999-4915/12/2/135
Cited by 684 | Viewed by 91557
4. “Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections”
by David A. Schwartz et al.
Viruses 2020, 12(2), 194; https://doi.org/10.3390/v12020194
Available online: https://www.mdpi.com/1999-4915/12/2/194
Cited by 545 | Viewed by 32959
5. “Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV”
by Jiabao Xu et al.
Viruses 2020, 12(2), 244; https://doi.org/10.3390/v12020244
Available online: https://www.mdpi.com/1999-4915/12/2/244
Cited by 399 | Viewed by 37502
6. “Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays”
by Katharine H. D. Crawford et al.
Viruses 2020, 12(5), 513; https://doi.org/10.3390/v12050513
Available online: https://www.mdpi.com/1999-4915/12/5/513
Cited by 341 | Viewed by 13192
7. “Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2”
by Nadin Younes et al.
Viruses 2020, 12(6), 582; https://doi.org/10.3390/v12060582
Available online: https://www.mdpi.com/1999-4915/12/6/582
Cited by 202 | Viewed by 13646
8. “Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins”
by Suhas Srinivasan et al.
Viruses 2020, 12(4), 360; https://doi.org/10.3390/v12040360
Available online: https://www.mdpi.com/1999-4915/12/4/360
Cited by 134 | Viewed by 16756
9. “The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner”
by Mizuki Yamamoto et al.
Viruses 2020, 12(6), 629; https://doi.org/10.3390/v12060629
Available online: https://www.mdpi.com/1999-4915/12/6/629
Cited by 133 | Viewed by 4236
10. “SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions”
by Mohammed Uddin et al.
Viruses 2020, 12(5), 526; https://doi.org/10.3390/v12050526
Available online: https://www.mdpi.com/1999-4915/12/5/526
Cited by 125 | Viewed by 14756